× Current Issue Archive Submit Article
Conflicts of Interest Copyright and Access Open access policy Editorial Policies Peer Review Policy Privacy Statement Publishing Ethics
Editor in chief Associate Editors Advisory Board International Editors
Contact Us About Us Aim & Scope Abstracting And Indexing Author Guidelines Join As Editor
Views: 1214 Downloads: 146

Higher placental activin-A (ACV-A) and inhibin-A (INH-A) in preeclampsia placenta mother compare to diabetic mother


,
  1. Department of Obstetric and Gynecology, School of Medicine, University of Wijaya Kusuma Surabaya, Surabaya, Indonesia.
  2. Internal Medicine, School of Medicine, University of Wijaya Kusuma Surabaya, Surabaya, Indonesia.

Abstract

Preeclampsia (PE) is a systemic disorder that appears during pregnancy and results in complications in more than 3-6% of deliveries in developed countries. This disease is also the largest leading cause of maternal mortality in many countries, especially in developing countries such as Indonesia. Hence, early diagnosis of preeclampsia is important in young pregnancy to decrease mortality. Recently, activin A and inhibin A were proposed as new candidates for biomarkers in early diabetes in pregnancy. However, there is no information regarding its value in pre-eclampsia and diabetic pregnancy. Herein we conduct a study to determine the value of activin-A and inhibin-A between of preeclampsia mother and a diabetes mellitus mother. Placental samples were collected from 87 mothers undergoing cesarian delivery, which were 29 samples from healthy mothers, 29 samples from diabetic mothers, and 29 samples from preeclampsia mothers. Placentas were obtained after the mother agreed to informed consent from 3 private hospitals in Surabaya. After undergoing processing and homogenizing, placenta tissue was measured for its activin-A and inhibin-A using the ELISA method. Activin-A level placental from the healthy mother group was 0.62 mIU / ml, diabetic mother group was 1.05 mIU / ml, and preeclampsia mother group was 1.23 mIU / ml. The average level of inhibin-A in healthy mothers was 0.45 mIU / ml, diabetes mother group was 0.97 mIU / ml, and preeclampsia mother group was 1.10 mIU / ml. The conclusion is that placental activin-A and inhibin-A levels both in preeclampsia pregnancy have higher values than in diabetes mothers.



Keywords: Activin-A, Diabetes mellitus, Inhibin-A, Preeclampsia


How to cite this article:
Vancouver
Gondo HK, Haryanti E. Higher placental activin-A (ACV-A) and inhibin-A (INH-A) in preeclampsia placenta mother compare to diabetic mother. J Adv Pharm Educ Res. 2024;14(3):15-7. https://doi.org/10.51847/QVCQHO6GxQ
APA
Gondo, H. K., & Haryanti, E. (2024). Higher placental activin-A (ACV-A) and inhibin-A (INH-A) in preeclampsia placenta mother compare to diabetic mother. Journal of Advanced Pharmacy Education and Research, 14(3), 15-17. https://doi.org/10.51847/QVCQHO6GxQ
Citation Formats:

Most viewed articles:


Contact Meral


Meral Publications
www.meralpublisher.com

Davutpasa / Zeytinburnu 34087
Istanbul
Turkey

Email: [email protected]
Tell: +905344998991